雅虎香港 搜尋

搜尋結果

  1. Amlodipine Sandoz tab 10 mg. amlodipine besylate. Packing/Price. 30's. MIMS Class. Calcium Antagonists, Anti-Anginal Drugs. ATC Classification. C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.

  2. SANDOZ HONG KONG LIMITED. Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our ambition is to be the world's leading and most valued generics company.

    • Rm 30-101, 30/F, The Gateway Tower 515 Canton RdTsim Sha TsuiHong Kong
    • 2881 5811
  3. Presentation/Packing. Form. Became tab. Packing/Price. 2 × 14's. Became (Carbinoxamine maleate 4 mg, pseudoephedrine HCl 60 mg): Relief of seasonal & allergic rhinitis & vasomotor rhinitis symptoms eg, sneezing, s.

  4. Dosage/Direction for Use. Childn ≥2 yr 10-15 mg/kg/dose every 4 hr. Max: 4 doses in 24 hr. Max duration of continued use w/o medical advice: 3 days. Click to view Panadol Children's Chewable Tablet detailed prescribing information.

  5. Laxative Adult & childn ≥12 yr 20 mL (4 tsp). Childn 10-11 yr 10 mL (2 tsp), 5-9 yr 5 mL (1 tsp). Bowel cleansing Adult ≥18 yr 45 mL. Use as directed. Start the dose a day before hospital appointment. Click to view Phosphosoda detailed prescribing information.

  6. Info. Slo-Theo. theophylline. Manufacturer: Ethypharm Industries. Distributor: Primal. Concise Prescribing Info. Contents. Theophylline. Indications/Uses. Continuous symptomatic treatment of persistent asthma & of other forms of COPD. Dosage/Direction for Use. Adult Initially 5-8 mg/kg/day. Usual effective dose: 7-12 mg/kg/day. Max: 800 mg/day.

  7. Tagrisso FC tab 40 mg. Packing/Price. 30's. Form. Tagrisso FC tab 80 mg. Packing/Price. 30's. Tagrisso (Osimertinib mesylate): Adjuvant treatment after complete tumour resection in adults w/ stage IB-IIIA NSCLC whose tumours have epidermal growth fac.